The Center is actively pursuing research in the field of Neuromodulation, in particular SCS for failed back surgery syndrome and other neuropathies. In addition, patients benefit from access to leading edge research and clinical trials:
Prospective, Randomized Study of Multicolumn Implantable Lead Stimulation for Predominant Low Back Pain (PROMISE).
The purpose of this study is to compare the effectiveness of spinal cord stimulation (SCS) plus optimal medical management (OMM) versus OMM alone in patients suffering from predominant low back pain due to failed back surgery syndrome (FBSS).
A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain. (RELIEF)
The purpose of this study is to compile characteristics of real-world clinical outcomes and to evaluate the economic value and technical performance for a commercially approved neurostimulation system for pain in routine clinical practice.
For more information contact Translational Pain Research at (585) 340-8926 or email@example.com